145 related articles for article (PubMed ID: 34039026)
1. CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia.
Kou Z; Mao M; Liu H; Wang X; Wang Z; Gu Z; Lang T; Nie Y; Wang Y; Huang Q; An L; Zhang X; Fu L; Li Y
Biomark Med; 2021 Jun; 15(9):623-635. PubMed ID: 34039026
[No Abstract] [Full Text] [Related]
2. [Expression Level and Target Gene Prediction of miR-181b in Patients with Chronic Lymphocytic Leukemia].
Kou Z; Liu H; Wang YC; Huang Q; Wang ZS; Gu ZNE; Lang T; Nie YL; An L; A ZL; Mu HBE; Zhang XY; Fu L; Ai HJ; Mao M; Wang XM; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):808-814. PubMed ID: 32552940
[TBL] [Abstract][Full Text] [Related]
3. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
[TBL] [Abstract][Full Text] [Related]
4. miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.
Bresin A; Callegari E; D'Abundo L; Cattani C; Bassi C; Zagatti B; Narducci MG; Caprini E; Pekarsky Y; Croce CM; Sabbioni S; Russo G; Negrini M
Oncotarget; 2015 Aug; 6(23):19807-18. PubMed ID: 26090867
[TBL] [Abstract][Full Text] [Related]
5. miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
Sharma S; Pavlasova GM; Seda V; Cerna KA; Vojackova E; Filip D; Ondrisova L; Sandova V; Kostalova L; Zeni PF; Borsky M; Oppelt J; Liskova K; Kren L; Janikova A; Pospisilova S; Fernandes SM; Shehata M; Rassenti LZ; Jaeger U; Doubek M; Davids MS; Brown JR; Mayer J; Kipps TJ; Mraz M
Blood; 2021 May; 137(18):2481-2494. PubMed ID: 33171493
[TBL] [Abstract][Full Text] [Related]
6. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia.
Visone R; Veronese A; Rassenti LZ; Balatti V; Pearl DK; Acunzo M; Volinia S; Taccioli C; Kipps TJ; Croce CM
Blood; 2011 Sep; 118(11):3072-9. PubMed ID: 21636858
[TBL] [Abstract][Full Text] [Related]
7. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
[TBL] [Abstract][Full Text] [Related]
8. MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia.
Visone R; Veronese A; Balatti V; Croce CM
Oncotarget; 2012 Feb; 3(2):195-202. PubMed ID: 22350310
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA LINC01260 Inhibits the Proliferation, Migration and Invasion of Spinal Cord Glioma Cells by Targeting CARD11 Via the NF-κB Signaling Pathway.
Wu DM; Han XR; Wen X; Wang S; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Zheng YL
Cell Physiol Biochem; 2018; 48(4):1563-1578. PubMed ID: 30071522
[TBL] [Abstract][Full Text] [Related]
10. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
[TBL] [Abstract][Full Text] [Related]
11. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
[TBL] [Abstract][Full Text] [Related]
13. The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
Bomben R; Gobessi S; Dal Bo M; Volinia S; Marconi D; Tissino E; Benedetti D; Zucchetto A; Rossi D; Gaidano G; Del Poeta G; Laurenti L; Efremov DG; Gattei V
Leukemia; 2012 Jul; 26(7):1584-93. PubMed ID: 22343732
[TBL] [Abstract][Full Text] [Related]
14. The involvement of microRNA in the pathogenesis of Richter syndrome.
Van Roosbroeck K; Bayraktar R; Calin S; Bloehdorn J; Dragomir MP; Okubo K; Bertilaccio MTS; Zupo S; You MJ; Gaidano G; Rossi D; Chen SS; Chiorazzi N; Thompson PA; Ferrajoli A; Bertoni F; Stilgenbauer S; Keating MJ; Calin GA
Haematologica; 2019 May; 104(5):1004-1015. PubMed ID: 30409799
[TBL] [Abstract][Full Text] [Related]
15. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency.
Lu HY; Sharma M; Sharma AA; Lacson A; Szpurko A; Luider J; Dharmani-Khan P; Shameli A; Bell PA; Guilcher GMT; Lewis VA; Vasquez MR; Desai S; McGonigle L; Murguia-Favela L; Wright NAM; Sergi C; Wine E; Overall CM; Suresh S; Turvey SE
J Allergy Clin Immunol; 2021 Dec; 148(6):1559-1574.e13. PubMed ID: 33872653
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.
Rodríguez-Vicente AE; Quwaider D; Benito R; Misiewicz-Krzeminska I; Hernández-Sánchez M; de Coca AG; Fisac R; Alonso JM; Zato C; de Paz JF; García JL; Sarasquete ME; Hernández JÁ; Corchado JM; González M; Gutiérrez NC; Hernández-Rivas JM
BMC Cancer; 2015 Apr; 15():238. PubMed ID: 25880332
[TBL] [Abstract][Full Text] [Related]
20. Identification of key candidate genes and miRNA‑mRNA target pairs in chronic lymphocytic leukemia by integrated bioinformatics analysis.
Gao C; Zhou C; Zhuang J; Liu L; Wei J; Liu C; Li H; Sun C
Mol Med Rep; 2019 Jan; 19(1):362-374. PubMed ID: 30431072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
